Alembic Pharmaceuticals

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue1,4881,5921,4821,4791,596
Expenses1,3541,3351,2661,2661,409
EBITDA216.41340.44295.41294.57275.55
EBIT149.23271.36226.29225.89218.30
Profit Before Tax133.84256.70216.16213.20200.02
Net Profit133.84233.24201.87176.19165.78
Financial Ratios
Operating Profit Margin14.63%21.43%20.03%19.96%18.25%
Net Profit Margin9.05%14.68%13.69%11.94%9.81%
Earning Per Share (Diluted)6.8111.8710.278.968.43
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ